Related references
Note: Only part of the references are listed.Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Talimogene laherparepvec: First in class oncolytic virotherapy
Robert M. Conry et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Application of biodegradable dendrigraft poly-l-lysine to a small interfering RNA delivery system
Yukinobu Kodama et al.
JOURNAL OF DRUG TARGETING (2017)
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Tae Jin Lee et al.
MOLECULAR THERAPY (2017)
S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma
Kin-Hoe Chow et al.
CANCER RESEARCH (2017)
Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma
Matheus H. W. Crommentuijn et al.
MOLECULAR ONCOLOGY (2016)
Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain
Panagiotis Mastorakos et al.
SMALL (2016)
Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer
Song Gao et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Dipeptide-functionalized polyamidoamine dendrimer-mediated apoptin gene delivery facilitates apoptosis of human primary glioma cells
Yoonhee Bae et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
DNA repair mechanisms and their clinical impact in glioblastoma
Helene Erasimus et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma
Dwijit GuhaSarkar et al.
NEURO-ONCOLOGY (2016)
EPT-14PHASE I STUDY OF GENE MEDIATED CYTOTOXIC IMMUNOTHERAPY WITH AdV-tk AS ADJUVANT TO SURGERY AND RADIATION THERAPY FOR PEDIATRIC MALIGNANT GLIOMA AND RECURRENT EPENDYMOMA
Mark W. Kieran et al.
NEURO-ONCOLOGY (2016)
Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma
Lee A. Wheeler et al.
NEURO-ONCOLOGY (2016)
Harnessing the PEG-cleavable strategy to balance cytotoxicity, intracellular release and the therapeutic effect of dendrigraft poly-L-lysine for cancer gene therapy
Min Tang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo
Antonella Mangraviti et al.
ACS NANO (2015)
Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine
Sang-Soo Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system
Hui Yao et al.
BIOMATERIALS (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Sajeel A. Chowdhary et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
Sang-Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Glioblastoma multiforme: Pathogenesis and treatment
Constantinos Alifieris et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Nanomedicine to overcome radioresistance in glioblastoma stem-like cells and surviving clones
Delphine Sehedic et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
Meena Jhanwar-Uniyal et al.
CANCERS (2015)
Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo
Hugo Guerrero-Cazares et al.
ACS NANO (2014)
A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
Sang-Soo Kim et al.
ACS NANO (2014)
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
Yi Shu et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy
Jing Wang et al.
BIOCONJUGATE CHEMISTRY (2014)
The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers
Shaofei Wang et al.
BIOMATERIALS (2014)
Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector
M. Takahashi et al.
CANCER GENE THERAPY (2014)
Biodegradable nanoparticles composed of dendrigraft poly-L-lysine for gene delivery
Yukinobu Kodama et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
A Bacteria Deriving Peptide Modified Dendrigraft Poly-L-lysines (DGL) Self-Assembling Nanoplatform for Targeted Gene Delivery
Yang Liu et al.
MOLECULAR PHARMACEUTICS (2014)
INTRATUMORAL DELIVERY OF THE RETROVIRAL REPLICATING VECTOR (RRV) TOCA 511 IN SUBJECTS WITH RECURRENT HIGH GRADE GLIOMA: INTERIM REPORT OF PHASE 1 STUDY (NCT 01156584)
Manish Aghi et al.
NEURO-ONCOLOGY (2014)
TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion
J. V. Joseph et al.
CELL DEATH & DISEASE (2014)
Standards of care and novel approaches in the management of glioblastoma multiforme
Andreas F. Hottinger et al.
CHINESE JOURNAL OF CANCER (2014)
Choline transporter-targeting and co-delivery system for glioma therapy
Jianfeng Li et al.
BIOMATERIALS (2013)
Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model
T. T. Huang et al.
CANCER GENE THERAPY (2013)
A bioreducible linear poly(β-amino ester) for siRNA delivery
Kristen L. Kozielski et al.
CHEMICAL COMMUNICATIONS (2013)
T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting
Yuyang Kuang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery
Yang Lei et al.
JOURNAL OF GENE MEDICINE (2013)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2013)
Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells
Xiaozhi Liu et al.
ONCOLOGY REPORTS (2013)
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Samuel A. Jensen et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Subtle Changes to Polymer Structure and Degradation Mechanism Enable Highly Effective Nanoparticles for siRNA and DNA Delivery to Human Brain Cancer
Stephany Y. Tzeng et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Mechanisms of Glioma-Associated Neovascularization
Matthew E. Hardee et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Gene and doxorubicin co-delivery system for targeting therapy of glioma
Shuhuan Liu et al.
BIOMATERIALS (2012)
Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat
Du Cheng et al.
BIOMATERIALS (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo
Changyou Zhan et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Uptake and Transfection with Polymeric Nanoparticles Are Dependent on Polymer End-Group Structure, but Largely Independent of Nanoparticle Physical and Chemical Properties
Joel C. Sunshine et al.
MOLECULAR PHARMACEUTICS (2012)
Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration
Rongqin Huang et al.
BIOMATERIALS (2011)
Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma
Shixian Huang et al.
BIOMATERIALS (2011)
Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
E. Antonio Chiocca et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery
Yang Liu et al.
BIOMATERIALS (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo
Chunsheng Kang et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Polymeric Micelles in Anticancer Therapy: Targeting, Imaging and Triggered Release
Chris Oerlemans et al.
PHARMACEUTICAL RESEARCH (2010)
IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
Takuya Watanabe et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
PAMAM-RGD Conjugates Enhance siRNA Delivery Through a Multicellular Spheroid Model of Malignant Glioma
Carolyn L. Waite et al.
BIOCONJUGATE CHEMISTRY (2009)
The use of folate-PEG-grafted-hybranched-PEI nonviral vector for the inhibition of glioma growth in the rat
Bing Liang et al.
BIOMATERIALS (2009)
Characteristics of compounds that cross the blood-brain barrier
William A. Banks
BMC NEUROLOGY (2009)
Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-β
D. H. Meijer et al.
CANCER GENE THERAPY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
FDA Drug Approval Summary: Bevacizumab (Avastin (R)) as Treatment of Recurrent Glioblastoma Multiforme
Martin H. Cohen et al.
ONCOLOGIST (2009)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Neurotropism of herpes simplex virus type 1 in brain organ cultures
Efrat Braun et al.
JOURNAL OF GENERAL VIROLOGY (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma:: Biological and clinical results
FF Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery
DG Anderson et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2003)
Neurotropism and retrograde axonal transport of a canine adenoviral vector: A tool for targeting key structures undergoing neurodegenerative processes
E Peltekian et al.
MOLECULAR THERAPY (2002)
Changing the chemokine gradient: CINC1 crosses the blood-brain barrier
WH Pan et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
AM Sandmair et al.
HUMAN GENE THERAPY (2000)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Share Paper
